Author： Ooba Nobuhiro Sato Tsugumichi Watanabe Hikaru Kubota Kiyoshi
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.33, Iss.1, 2010-01, pp. : 35-45
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Segal Eleanor S. Valette Cecile Oster Laurence Bouley Luc Edfjall Catarina Herrmann Peter Raineri Massimo Kempff Mary Beacham Saundra Cinda van Lierop
Drug Safety, Vol. 28, Iss. 11, 2005-01 ,pp. :
Access to resources
Recommend
Risk Management for Biological Products
International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 3, 2004-01 ,pp. :
The Xyrem ® Risk Management Program
By Fuller D.E. Hornfeldt C.S. Kelloway J.S. Stahl P.J. Anderson T.F.
Drug Safety, Vol. 27, Iss. 5, 2004-01 ,pp. :
Risk management in the NHS: governance, finance and clinical risk
Clinical Medicine, Vol. 12, Iss. 1, 2012-02 ,pp. :